---
title: "Xarelto (rivaroxaban) in nonvalvular atrial fibrillation: Indication questions"
description: "Indication questions on Xarelto (rivaroxaban) in nonvalvular atrial fibrillation, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Questions: What is Xarelto approved for in atrial fibrillation? What does nonvalvular atrial fibrillation mean for Xarelto (ROCKET AF)? 2 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/indication"
published: "2026-11-13T03:43:41-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Xarelto (rivaroxaban) in nonvalvular atrial fibrillation: Indication questions

Manufacturer: Janssen Pharmaceuticals, Inc.  
Prescribing information: [Xarelto](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf)

Indication questions that apply to every indication of Xarelto are on [Xarelto (rivaroxaban), all indications: Indication](https://www.evicenter.com/medical-information/xarelto/indication).

## Indication

<a id="xarelto-nvaf-indication"></a>

### What is Xarelto approved for in atrial fibrillation?

> “XARELTO is indicated to reduce the risk of stroke and systemic embolism in adult 
> patients with nonvalvular atrial fibrillation.
> There are limited data on the relative effectiveness of XARELTO and warfarin in 
> reducing the risk of stroke and systemic embolism when warfarin therapy is 
> well-controlled [see Clinical Studies (14.1)].”

Source: [XARELTO: Prescribing information, page 3, captured 2026-11-13](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/XARELTO-pi.pdf#page=3)

Note: Prescribing Information revised 03/2026, linked as "US Prescribing Information" from every page of the Xarelto HCP site.

<a id="xarelto-nvaf-definition"></a>

### What does nonvalvular atrial fibrillation mean for Xarelto (ROCKET AF)?

> “In ROCKET AF, NVAF was defined as atrial fibrillation in the absence of hemodynamically significant mitral valve stenosis or a prosthetic heart valve. However, patients with mitral valve repair, such as annuloplasty with or without prosthetic ring, commissurotomy, and/or valvuloplasty, were permitted.<sup>1</sup>”

Source: [XARELTO: Frequently Asked Questions (FAQs), captured 2026-11-13](https://www.xareltohcp.com/faqs/#general-questions:~:text=In%20ROCKET%20AF%2C%20NVAF%20was,ring%2C%20commissurotomy%2C%20and%2For%20valvuloplasty%2C%20were)

This passage is in a collapsed section of the page; select: How was NVAF defined in ROCKET AF?

Note: This is the definition used in the ROCKET AF trial, from the FAQ page of the Xarelto HCP site; the Prescribing Information does not define nonvalvular atrial fibrillation. See also the question on prosthetic heart valves.

## Related pages
- [Medical information: Xarelto (rivaroxaban): Nonvalvular atrial fibrillation](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation)
- [Clinical trials](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/clinical-trials)
- [Real-world evidence](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/real-world-evidence)
- [Safety](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/safety)
- [Specific populations](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/specific-populations)
- [Dosing and administration](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/dosing-and-administration)
- [Access and coverage](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/access-and-coverage)
- [Guidelines](https://www.evicenter.com/medical-information/xarelto--nonvalvular-atrial-fibrillation/guidelines)
